Skip to main content
    D

    Dogwood Therapeutics, Inc. (DWTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.28
    +0.24 (+23.08%)

    Market Cap: $39.76M

    Last updated: Nov 06, 2026 at 4:34 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(15/23)
    Avg Surprise
    -539.50%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$-0.38
    Range$-0.46 - $-0.31
    2 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    3 analysts
    Last 12 of 26 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$-0.38$-0.46 - $-0.31--2--
    Sep 26
    Reported Nov 5
    		$-0.14$-0.15$-0.16 - $-0.15+6.67%Beat2
    0
    2
    30d
    		+98.3%
    Jun 26
    Reported Aug 13
    		$-0.34$-0.13$-0.15 - $-0.13-161.54%Miss3
    2
    0
    30d
    		+82.9%
    Mar 26
    Reported May 14
    		$-0.15$-0.20$-0.30 - $-0.13+25.00%Beat3
    1
    0
    30d
    		+98.2%
    Dec 25
    Reported Mar 18
    		$-0.26N/A-+69.77%Beat3
    1
    0
    30d
    		+95.9%
    Sep 25
    Reported Nov 6
    		$-8.20$-1.58$-2.30 - $-0.45-418.99%Miss3
    1
    0
    30d
    		-300.0%
    Jun 25
    Reported Aug 13
    		$-1.99$-1.90--4.74%Miss---59.2%
    Mar 25
    Reported May 8
    		$-8.45$-0.76$-0.76 - $-0.76-1011.84%Miss0
    No revisions (30d)
    		-382.9%
    Dec 24
    Reported Feb 26
    		$-6.29$-0.06$-0.06 - $-0.06-10993.47%Miss0
    No revisions (30d)
    		-10383.3%
    Sep 24
    Reported Nov 7
    		$-2.05$-1.18--73.73%Miss---36.7%
    Jun 24
    Reported Aug 8
    		$-1.25$-1.58-+20.89%Beat--+37.5%
    Mar 24
    Reported May 9
    		$-1.75$-1.00--75.00%Miss---2087.5%
    Dec 23
    Reported Feb 29
    		$-0.06$-0.06-+0.00%Beat--+97.8%

    Key Metrics

    Valuation
    P/E Ratio-1.44EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-47.80%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio2.78xQuick Ratio2.78x
    Trading Statistics
    Beta2.11Avg Volume98.41K
    52-Week High$7.0452-Week Low$0.90

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.16
    SMA 20$1.19
    SMA 50$1.54
    SMA 200$1.93
    EMA 10$1.16
    EMA 20$1.22
    EMA 50$1.43
    EMA 200$2.17

    MACD

    Line: -0.10Signal: -0.12Hist: 0.02

    ADX

    ADX: 18.6+DI: 27.9-DI: 28.6

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down88.0
    PSAR$0.90

    Bollinger Bands

    Upper Band$1.38
    Lower Band$1.00
    %B Position3147%(Upper)
    Band Width0.74

    RSI (14-Day)

    Neutral
    50.2

    Momentum Oscillators

    Stoch %K44.3
    Stoch %D34.8
    Williams %R-20.9
    ROC (10d)14.3%
    Momentum0.16
    CCI (20d)34.1
    MFI (14d)42.7

    Volatility Measures

    ATR (14d)$0.15(11.8%)
    StdDev (20d)0.09
    Hist Vol112.2%(High)

    Volume Flow

    VWAP$1.24
    OBV38.9M
    AD Line-18.1M
    CMF (20d)-0.226

    Volume Metrics

    Avg Vol (20d)101.8K
    Vol Ratio1.6x(High)
    VWMA (20d)$1.16

    Pivot Points

    R3$1.25
    R2$1.15
    R1$1.10
    Pivot Point$1.00
    S1$0.95
    S2$0.85
    S3$0.80

    Advanced Oscillators

    TSI-29.02
    Ultimate Osc46.2
    KST-217.43

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$100,000$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$88,104$0$0N/A$0$0$0$12,177$0$0$0N/A
    Gross Profit$11,896$0$0N/A$0$0$0$-12,177$0$0$0N/A
    Operating Expenses$4.93M$14.06M$5.08M$3.81M$15.81M$3.92M$4.43M$7.54M$2.30M$1.07M$1.31M$1.14M
    R&D$3.35M$3.25M$2.67M$2.34M$14.52M$2.57M$2.44M$2.32M$535,162$336,084$343,717$298,321
    SG&A$1.58M$1.63M$2.41M$1.47M$1.29M$1.35M$1.99M$5.23M$1.77M$733,740$970,384$839,805
    Operating Income$-4,917,300$-14,063,525$-5,076,366$-3,806,279$-15,809,125$-3,923,115$-4,429,926$-7,542,151$-2,301,172$-1,069,824$-1,314,101$-1,138,126
    Interest Income$42,035$66,349$77,350$52,067$80,582$111,379$-147,090$-155,437$20,488$19,991$22,766$0
    Interest Expense$0$0$0$0$0$0$6.13M$186,224$0$0$0$0
    Income Before Tax$-4,883,781$-14,010,303$-4,985,421$-3,748,608$-15,746,052$-3,807,204$-10,734,410$-7,728,375$-2,280,684$-1,049,833$-1,291,335$-1,103,173
    Income Tax Expense$-839$-2,480,694$1,193$31,841$-1,436$149$190,542$-503$0$0$0$0
    Net Income$-4,882,942$-11,529,609$-4,986,614$-3,780,449$-15,744,616$-3,807,353$-10,924,952$-7,727,872$-2,280,684$-1,049,833$-1,291,335$-1,103,173
    EBITDA$-4,925,816$-14,076,652$-5,082,226$-3,797,944$-15,858,849$-3,901,327$-4,383,805$-7,502,329$-2,301,172$-1,069,824$-1,314,101$-1,138,126
    EBIT$-4,925,816$-14,076,652$-5,082,226$-3,797,944$-15,826,634$-3,918,583$-4,453,200$-7,572,938$-2,301,172$-1,069,824$-1,314,101$-1,138,126
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about DWTX

    News

    No news available

    Company news will appear here when available

    DWTX Valuation and Fair Value

    P/E
    -1.4x
    P/B
    0.7x
    See GNG's fair value

    DWTX Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -47.8%
    FCF margin
    -16471.8%

    DWTX Competitors

    CompanyTicker
    CryoCell International IncCCEL
    Genenta Science SpA ADRGNTA
    Actinium Pharmaceuticals IncATNM
    FibroGen IncFGEN
    Xtant Medical Holdings IncXTNT
    CVRx IncCVRX
    Serina Therapeutics IncSER
    Hyperion DeFi, Inc.HYPD

    Sector: Healthcare

    DWTX Bull Case vs Bear Case

    Bear case

    • DWTX beat EPS estimates in 37.5% of its last 8 reported quarters.

    DWTX Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -213.7%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $-0.38

    DWTX Earnings Date

    DWTX reports Mar 16, 2027, after the close. The date is estimated.

    DWTX ETF Holders

    GNG tracks 1 ETF that holds DWTX.

    1. Vanguard Extended Market Index Fund ETF Shares (VXF), <0.01% of the fund
    Open the ETF Stock Exposure tool for DWTX

    Frequently Asked Questions About DWTX

    When does DWTX report earnings?

    Dogwood Therapeutics, Inc. (DWTX) is expected to report earnings on Mar 16, 2027.

    Does DWTX pay dividends?

    Dogwood Therapeutics, Inc. (DWTX) does not currently pay a regular dividend.

    What is DWTX's market cap?

    Dogwood Therapeutics, Inc. (DWTX) has a market capitalization of $39.76M with a current stock price of $1.28.

    Related stocks

    Sector: Healthcare

    All stocks starting with D

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In